Low serum mannose-binding lectin as a risk factor for new onset diabetes mellitus after renal transplantation

Transplantation

Volumn 88, Issue 2, 2009, Pages 272-278

  Ibernon, Meritxell ^a   Moreso, Francesc ^b   Moreno, José M ^c   Bestard, Oriol ^b   Cruzado, Josep M ^b   Grinyó, Josep M ^b   Ricart, Wifredo ^c   Fernández Real, José M ^c   Serón, Daniel ^b  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^c Instituto de Salud Carlos III   (Spain)

Author keywords

Chronic inflammation; Diabetes mellitus; Infection; Mannose binding lectin; Renal transplantation

Indexed keywords

BELATACEPT; CYCLOSPORIN A; EVEROLIMUS; MANNOSE BINDING LECTIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; RAPAMYCIN; TACROLIMUS; TUMOR NECROSIS FACTOR RECEPTOR 2;

ADULT; ARTICLE; BACTERIAL INFECTION; BLOOD LEVEL; BODY MASS; CHRONIC INFLAMMATION; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GLUCOSE HOMEOSTASIS; GRAFT SURVIVAL; HEMODIALYSIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; IMPAIRED GLUCOSE TOLERANCE; INCIDENCE; INNATE IMMUNITY; KIDNEY FUNCTION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; MYCOSIS; ORAL GLUCOSE TOLERANCE TEST; PERITONEAL DIALYSIS; POSTOPERATIVE INFECTION; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; STATISTICAL SIGNIFICANCE; UNIVARIATE ANALYSIS;

BIOLOGICAL MARKERS; DIABETES MELLITUS; GLUCOSE TOLERANCE TEST; GRAFT SURVIVAL; HUMANS; INFECTION; INFLAMMATION; KIDNEY TRANSPLANTATION; MANNOSE-BINDING LECTIN; POSTOPERATIVE COMPLICATIONS; PREVALENCE; RISK FACTORS;

EID: 68249111407     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181ac8e36     Document Type: Article

References (44)

1. Medzhitov R, Janeway C. Innate immunity. N Eng J Med 2000; 343: 338.
2. Schmidt MI, Duncan BB, Sharrett AR, et al. Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities Study): A cohort study. Lancet 1999; 353: 1649.
3. Plomgaard P, Nielsen AR, Fischer CP, et al. Associations between insulin resistance and TNF-α skeletal muscle and adipose tissue in humans with and without type 2 diabetes. Diabetologia 2007; 50: 2562.
4. Pickup JC, Crook MA. Is type 2 diabetes mellitus a disease of the innate immune system? Diabetologia 1998; 41: 695.
5. Garred P, Larsen F, Seyfarth J, et al. Mannose-binding lectin and its genetic variants. Genes Immun 2006; 7: 85.
6. Bouwman LH, Roep BO, Roos A. Mannose-binding lectin: Clinical implications for infection, transplantation and autoimmunity. Hum Immunol 2006; 67: 247.
7. Megia A, Gallart L, Fernández-Real JM, et al. Mannose-binding lectin gene polymorphisms are associated with gestational diabetes mellitus. J Clin Endocrinol Metab 2004; 89: 5081.
8. Fernández-Real JM, Straczkowski M, Vendrell J, et al. Protection from inflammatory disease in insulin resistance: The role of mannan-binding lectin. Diabetologia 2006; 49: 2402.
9. Fishman JA, Rubin RH. Infection in organ-transplant recipients. N Engl J Med 1998; 338: 1741.
10. Kasiske BL, Snyder JJ, Gilbertson D, et al. Diabetes mellitus after kidney transplantation in the United States. Am J Transplant 2003; 3: 178.
11. Cosio FG, Pesavento TE, Osei K, et al. Postransplant diabetes mellitus: Increasing incidence in renal allograft recipients transplanted in recent years. Kidney Int 2001; 59: 732.
12. Porrini E, Moreno JM, Osuna A, et al. Prediabetes in patients receiving tacrolimus in the first year after kidney transplantation: A prospective and multicenter study. Transplantation 2008; 85: 1133.
13. Anonymous. Diagnosis and classification of diabetes mellitus. Diabetes Care 2005; 28: S37.
14. Solez K, Colvin RB, Racusen LC, et al. Banff 07 classification of renal allograft pathology: Updates and future directions. Am J Transplant 2008; 8: 753.
15. Fernandez-Real JM, Pickup JC. Innate immunity, insulin resistance and type 2 diabetes. Trends Endocrinol Metab 2008; 19: 10.
16. Rugonfalvi-Kiss S, Endrész V, Madsen HO, et al. Association of Chlamydia pneumoniae with coronary artery disease and its progression its dependent on the modifying effect of mannose-binding lectin. Circulation 2002; 27: 1071.
17. Cosio FG, Pesavento TE, Kim S, et al. Patient survival after renal transplantation. IV. Impact of post-transplant diabetes. Kidney Int 2002; 62: 1440.
18. González-Posada JM, Hernández D, Genís BB, et al. Increased cardiovascular risk profile and mortality in kidney allograft recipients with post-transplant diabetes mellitus in Spain. Clin Transplant 2006; 20: 650.
19. Hjelmesaeth J, Hartmann A, Leivestead T, et al. The impact of early-diagnosed new-onset post-transplantation diabetes mellitus on survival and major cardiac events. Kidney Int 2006; 69: 588.
20. Lansang MC, Ma L, Schold JD, et al. The relationship between diabetes and infectious hospitalizations in renal transplant recipients. Diabetes Care 2006; 29: 1659.
21. Davidson J, Wilkinson A, Dantal J, et al. New-onset diabetes after transplantation: 2003 international consensus guidelines. Transplantation 2003; 75: SS3.
22. Garred P, Larsen F, Madsen HO, et al. Mannose-binding lectin deficiency-revisited. Mol Immunol 2003; 40: 73.
23. Satomura A, Endo M, Ohi H, et al. Significant elevations in serum mannose-binding lectin levels in patients with chronic renal failure. Nephron 2002; 92: 702.
24. Thiel S, Holmskov U, Hviid L, et al. The concentration of C-type lectin mannan-binding protein, in human plasma increases during an acute phase response. Clin Exp Immunol 1992; 90: 31.
25. Nielsen OL, Jensenius JC, Jorgensen PH, et al. Serum levels of chicken mannan-binding lectin (MBL) during virus infections; indication that chicken MBL is an acute phase reactant. Vet Immunopathol 1999; 70: 309.
26. Aittoniemi J, Rintala E, Miettinen A, et al. Serum mannan-binding lectin (MBL) in patients with infection: Clinical and laboratory correlates. APMIS 1997; 105: 617.
27. Perez-Castellano M, Peñaranda M, Payeras A, et al. Mannose binding lectin does not act as an acute phase reactant with community acquired pneumococcal pneumonia. Clin Exp Immunol 2006; 145: 228.
28. Cueto-Manzano AM, Morales-Buenrostro LE, Gonzalez-Espinosa L, et al. Markers of inflammation before and after renal transplantation. Transplantation 2005; 80: 47.
29. Hollander AA, Hene RJ, Hermans J, et al. Late prednisone withdrawal in cyclosporine treated transplant patients: A randomized study. J Am Soc Nephrol 1997; 8: 294.
30. Milgrom M, Esquenazi V, Fuller L, et al. Posttransplant hyperglycemia. Increased incidence in cyclosporine-treated renal allograft recipients. Transplantation 1989; 47: 278.
31. Johnston O, Rose CL, Webster AC, et al. Sirolimus is associated with new-onset diabetes in kidney transplant recipients. J Am Soc Nephrol 2008; 19: 1411.
32. Duijnhoven EM, Boots JM, Christiaans MH, et al. Influence of tacrolimus on glucose metabolism before and after renal transplantation: A prospective study. J Am Soc Nephrol 2001; 12: 503.
33. Larsen JL, Bennett RG, Burkman T, et al. Tacrolimus and sirolimus cause insulin resistance in normal Sprague Dawley rats. Transplantation 2006; 82: 466.
34. Bloom RD, Rao V, Weng F, et al. Association of hepatitis C with postransplant diabetes in renal transplant patients on tacrolimus. J Am Soc Nephrol 2002; 13: 1374.
35. First MR, Gerber DA, Hariharan S, et al. Posttransplant diabetes mellitus in kidney allograft recipients: Incidence, risk factors and management. Transplantation 2002; 73: 379.
36. Hundal RS, Petersen KF, Mayerson AB, et al. Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes. J Clin Invest 2002; 109: 1321.
37. Aderka D. The potential biological and clinical significance of the soluble tumor necrosis factor receptors. Cytokine Growth Factor Rev 1996; 7: 231.
38. Xu S, Venge P. Lipocalins as biochemical markers of disease. Biochim Biophys Acta 2000; 1482: 298.
39. Hibberd ML, Sumiya M, Sommerfield JA, et al. Association of variants of the gene for mannose-binding lectin with susceptibility to meningococcal disease. Meningococcal Research Group. Lancet 1999; 353: 1049.
40. Mullighan CG, Heatley S, Doherty K, et al. Mannose-binding lectin gene polymorphisms are associated with major infection following allogenic hemopoietic stem cell transplantation. Blood 2002; 99: 3524.
41. Bowman LH, Roos A, Terpstra OT, et al. Mannose binding lectin gene polymorphisms confer a major risk for severe infections after liver transplantation. Gastroenterology 2005; 129: 408.
42. Verschuren JW, Roos A, Schaapherder FM, et al. Infectious complications after simultaneous pancreas-kidney transplantation: A role for the lectin pathway of complement activation. Transplantation 2008; 85: 75.
43. Manuel O, Pascual M, Trendelenburg M, et al. Association between mannose-binding lectin deficiency and cytomegalovirus infection after kidney transplantation. Transplantation 2007; 83: 359.
44. Cervera C, Lozano F, Saval N, et al. The influence of innate immunity gene receptors polymorphisms in renal transplant infections. Transplantation 2007; 83: 1493.